Skip to main content

Table 4 Clinical Manifestation of Patients Versus Serum Triglyceride

From: The relationship between serum triglyceride levels and acute pancreatitis in an animal model and a 14-year retrospective clinical study

 

Normal

Mild HTG

Moderate HTG

Severe HTG

χ2

P

Pancreatic effusion

419(43.3%)

237 (58.7%)

98 (79.7%)

77 (78.6%)

101.78

0.000

Pancreatic pseudocyst

92 (9.5%)

44 (10.6%)

11 (9.0%)

4 (4.1%)

3.92

0.264

Pancreatic necrosis

129(13.3%)

84 (28.6%)

49 (20.6%)

32 (32.7%)

69.74

0.000

Pancreatic abscess

15 (1.5%)

10 (2.4)

6 (4.8%)

4 (4.1%)

7.74

0.035

ACS

4 (0.4%)

6 (1.5%)

6 (4.8%)

2 (2.0%)

16.81

0.001

ARDS

27 (2.7%)

24 (5.5%)

14 (11.0%)

10 (9.8%)

28.50

0.000

Kidney injury

39 (3.8%)

28 (6.5%)

13 (10.2%)

19 (18.6%)

42.04

0.000

Hydropericardium

12 (1.2%)

6 (1.4%)

3 (2.4%)

0 (0%)

2.35

0.468

Arrhythmia

7 (0.7%)

3 (0.7%)

2 (1.6%)

0 (0%)

2.06

0.577

PE

3 (0.3%)

3 (0.7%)

1 (0.8%)

2 (2.0%)

5.58

0.089

DIC

5 (0.5%)

1 (0.2%)

2 (1.6%)

3 (2.9%)

8.97

0.018

Septicaemia

2 (0.2%)

2 (0.5%)

1 (0.8%)

1 (1.0%)

4.14

0.181

Fungal infection

5 (0.5%)

4 (0.9%)

2 (1.6%)

0 (0%)

3.03

0.296

Chronic pancreatitis

18 (1.8%)

8 (1.9%)

2 (1.7%)

0 (0%)

1.348

0.740

Hyperglycemia

55 (5.6%)

36 (8.7%)

11 (9.6%)

13 (14.0%)

12.776

0.005

Hydrothorax

301(32.4%)

170 (43.5%)

64 (54.7%)

57 (60.6%)

50.816

0.000